RealClearHealth November 24, 2015 Archives

RealClearHealth AM Update

'Growth Clouds' Looming for Health Spending?

Richard Foster HA Blog

Pfizer-Allergan Deal Is a Blow to R&D

Ed Silverman Pharmalot

Treasury Unlikely to Block Pfizer-Allergan Deal

Kevin McCoy USA Today

$710-a-Day Cystic Fibrosis Rx Strains Medicaid Budgets

Dave Gram AP

GOP Senators Press Obama on Drug Imports

Sarah Ferris The Hill

Conservative Groups Push Risk Corridors Rider

Will Dobbs-Allsopp MC

FDA Targets Inaccurate Medical Tests

Robert Pear New York Times

Regulatory Inaction Persists on 'Waived' Tests

Ellen Gabler MJS

Study: Off-Label Prescriptions Carry Higher Risks

Sumathi Reddy WSJ

ACP Calls for Greater Use of Generics

Brady Dennis Washington Post

Hospitals Broaden Community-Benefit Work

Beth Kutscher Modern HC

Feds Propose Expanded Role for Navigators

Sabrina Corlette CHIRblog

Health Care Inflation Reaches 6 Decade Low

Chris Conover Apothecary

Reauthorize the Older Americans Act

Henry Cisneros & Vin Weber Hill

The Pfizer-Allergan Merger Is a Disgrace

John Cassidy New Yorker

RealClearHealth PM Update

Drug Makers, Insurers Eye an Alliance on Prices

Dylan Scott Stat

Pfizer Weighs Splitting Up after Merger

Jonathan D. Rockoff WS Journal

End of Medicare Bonus Means Cut in Doctor Pay

Michelle Andrews KHN

Medicare Bundled Payments Are Here to Stay

Deirdre Wilson MedCity

Shaheen Calls for Funds to Fight Heroin Abuse

Niels Lesniewski Roll Call

Seniors Don't Pay For (All) Their Medicare

Chris Conover Apothecary

Is the ACA in Trouble?

Henry J. Aaron Inside Sources

How CMS Should Reimburse for Biosimilars

Tara Oâ??Neill AAF

RealClearHealth Research and Analysis

Bundled Payments Policy Brief

Amanda Cassidy Health Affairs

Medical Response to Paris Terrorist Attacks

Martin Hirsch et al. Lancet

U.S. Health Spending 1960-2013

Catlin & Cowan CMS Office of the Actuary